Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus

  • Jörg Schlender
    Max von Pettenkofer Institute and Gene Center
  • Veit Hornung
    Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
  • Stefan Finke
    Max von Pettenkofer Institute and Gene Center
  • Margit Günthner-Biller
    Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
  • Sabrina Marozin
    Max von Pettenkofer Institute and Gene Center
  • Krzysztof Brzózka
    Max von Pettenkofer Institute and Gene Center
  • Sharareh Moghim
    Max von Pettenkofer Institute and Gene Center
  • Stefan Endres
    Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
  • Gunther Hartmann
    Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
  • Karl-Klaus Conzelmann
    Max von Pettenkofer Institute and Gene Center

書誌事項

公開日
2005-05
権利情報
  • https://journals.asm.org/non-commercial-tdm-license
DOI
  • 10.1128/jvi.79.9.5507-5515.2005
公開者
American Society for Microbiology

この論文をさがす

説明

<jats:title>ABSTRACT</jats:title> <jats:p> Human plasmacytoid dendritic cells (PDC) are key sentinels alerting both innate and adaptive immune responses through production of huge amounts of alpha/beta interferon (IFN). IFN induction in PDC is triggered by outside-in signal transduction pathways through Toll-like receptor 7 (TLR7) and TLR9 as well as by recognition of cytosolic virus-specific patterns. TLR7 and TLR9 ligands include single-stranded RNA and CpG-rich DNA, respectively, as well as synthetic derivatives thereof which are being evaluated as therapeutic immune modulators promoting Th1 immune responses. Here, we identify the first viruses able to block IFN production by PDC. Both TLR-dependent and -independent IFN responses are abolished in human PDC infected with clinical isolates of respiratory syncytial virus (RSV), RSV strain A2, and measles virus Schwarz, in contrast to RSV strain Long, which we previously identified as a potent IFN inducer in human PDC (Hornung et al., J. Immunol. <jats:bold>173:</jats:bold> 5935-5943, 2004). Notably, IFN synthesis of PDC activated by the TLR7 and TLR9 agonists resiquimod (R848) and CpG oligodeoxynucleotide 2216 is switched off by subsequent infection by RSV A2 and measles virus. The capacity of RSV and measles virus of human PDC to shut down IFN production should contribute to the characteristic features of these viruses, such as Th2-biased immune pathology, immune suppression, and superinfection. </jats:p>

収録刊行物

  • Journal of Virology

    Journal of Virology 79 (9), 5507-5515, 2005-05

    American Society for Microbiology

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ